Your browser doesn't support javascript.
loading
Adefovir Dipivoxil / Adefovir Dipivoxil
Hevia-Urrutia, Francisco Javier.
  • Hevia-Urrutia, Francisco Javier; Hospital San Juan de Dios. CR
Acta méd. costarric ; 50(supl.3): 51-52, nov. 2008. tab
Article in Spanish | LILACS | ID: lil-700667
RESUMEN
El adefovir es un nucleótido que se utiliza por vía oral, sin resistencia conocida hasta los dos años de tratamiento. Actúa en los pacientes con hepatitis B crónica Age+ y Age-, es efectivo en resistentes a lamivudina. Es un medicamento bien tolerado en cirróticos descompensados y trasplantados. Se requiere ajuste de dosis con alteración de la función renal.
ABSTRACT
Adefovir is a nucleotide orally administrated with unknown resistance until two years of treatment. It is recommended for patients with chronic hepatitis B + and e -, it is resistant to Lamivudine. It is a well tolerated drug by decompensated, transplanted cirrhotic. Dose adjustment is required in renal impairment.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Hepatitis B / Nucleotides Limits: Humans Language: Spanish Journal: Acta méd. costarric Journal subject: Medicine Year: 2008 Type: Article Affiliation country: Costa Rica Institution/Affiliation country: Hospital San Juan de Dios/CR

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Hepatitis B / Nucleotides Limits: Humans Language: Spanish Journal: Acta méd. costarric Journal subject: Medicine Year: 2008 Type: Article Affiliation country: Costa Rica Institution/Affiliation country: Hospital San Juan de Dios/CR